- Laboratory characteristics of the studied non-chronic kidney disease and chronic kidney disease groups.
| Parameters | MAFLD patients | P-values | |
|---|---|---|---|
| Non-CKD group (n=80) | CKD group (n=84) | ||
| Serum uric acid(mg\dl) | 5.1±0.8 | 7.0±1.3 | <0.001* |
| Triglycerides(mg\dl) | 131.3±52.0 | 172.7±26.7 | <0.001* |
| Cholesterol(mg\dl) | 212.8±38.8 | 230.5±46.5 | 0.009* |
| Serum albumin(g/dl) | 4.0±0.3 | 3.5±0.5 | <0.001* |
| Bilirubin(mg\dl) | 1.0±0.1 | 1.0±0.2 | 0.142 |
| ALT (U\L) | 49.5±12.0 | 27.1±11.8 | <0.001* |
| AST (U\L) | 45.0±8.7 | 30.2±15.2 | <0.001* |
| Viral hepatitis markers | |||
| Negative | 76 (95.0) | 52 (61.9) | <0.001* |
| HCV positive | 4 (5.0) | 12 (14.3) | |
| HCV positive not received treatment | 0 (0.0) | 8 (9.5) | |
| HCV positive received treatment | 0 (0.0) | 12 (14.3) | |
Values are presented as mean ± standard deviation (SD) or numbers and percentages (%).
MAFLD: metabolic associated fatty liver disease, CKD: chronic kidney disease, ALT: alanine transaminase, AST: aspartate aminotransferase, HCV: hepatitis C
↵* Significant at a p-value of <0.05.